Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Thomas Yau(University of Hong Kong), Chiun Hsu(National Taiwan University), Tae‐You Kim(Seoul National University Hospital), Su-Pin Choo(National Cancer Centre Singapore), Yoon‐Koo Kang(Asan Medical Center), Ming‐Mo Hou(Chang Gung Memorial Hospital), Kazushi Numata(Yokohama City University Medical Center), Winnie Yeo(Chinese University of Hong Kong), Akhil Chopra(National Cancer Centre Singapore), Masafumi Ikeda(National Cancer Center Hospital East), Ryoko Kuromatsu(Kurume University Hospital), Michihisa Moriguchi(Kyoto Prefectural University of Medicine), Yee Chao(Taipei Veterans General Hospital), Huanyu Zhao(Bristol-Myers Squibb (United States)), Jeffrey Anderson(Bristol-Myers Squibb (United States)), Christine Dela Cruz(Bristol-Myers Squibb (United States)), Masatoshi Kudo(Kindai University)
Journal of Hepatology
June 7, 2019
Cited by 269Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis